HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.
Ismael N, Gemusse H, Mahumane I, Laurindo O, Magul C, Baxter C, Wilkinson E, Hofstra LM, Wagar N, Bila D, Mabunda N, da Silva J, Oliveira T, Raizes E, Preiser W, Manuel P, Ramos A, Vúbil A.
Ismael N, et al.
BMC Infect Dis. 2024 Jul 29;24(1):748. doi: 10.1186/s12879-024-09579-4.
BMC Infect Dis. 2024.
PMID: 39075381
Free PMC article.